Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Sanacora

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|October 12, 2005
Joint analysis of repeatedly observed continuous and ordinal measures of disease severityR V Gueorguieva, G Sanacora
Journal of the American Academy of Child and Adolescent Psychiatry|May 1, 1996
The need for outcome studiesR Chang, G Sanacora, R Sanchez
Journal of Neuroendocrinology|May 11, 2011
Developmental aspect of differences in hypothalamic preproneuropeptide y messenger ribonucleic Acid content in lean and genetically obese zucker ratsG Sanacora, J A Finkelstein, J D Whitet
Critical Reviews in Neurobiology|March 20, 2001
Impairment of GABAergic transmission in depression: new insights from neuroimaging studiesG Sanacora, G F Mason, J H Krystal
Endocrinology|August 1, 1990
Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivationG Sanacora, M Kershaw, J A Finkelstein, et al.
The Journal of ECT|April 3, 2001
ECS-Induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatmentA C Chen, K H Shin, R S Duman, et al.
General Hospital Psychiatry|August 14, 2018
Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editorR B Katz, M Toprak, S T Wilkinson, et al.
The Medical Clinics of North America|May 15, 2001
Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disordersJ H Krystal, D C D'Souza, G Sanacora, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 20, 2016
Balancing the Promise and Risks of Ketamine Treatment for Mood DisordersG Sanacora, H Heimer, D Hartman, et al.
Molecular Psychiatry|October 1, 2008
Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzoleM Banasr, G M I Chowdhury, R Terwilliger, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|October 12, 2005
Joint analysis of repeatedly observed continuous and ordinal measures of disease severityR V Gueorguieva, G Sanacora
Journal of the American Academy of Child and Adolescent Psychiatry|May 1, 1996
The need for outcome studiesR Chang, G Sanacora, R Sanchez
Journal of Neuroendocrinology|May 11, 2011
Developmental aspect of differences in hypothalamic preproneuropeptide y messenger ribonucleic Acid content in lean and genetically obese zucker ratsG Sanacora, J A Finkelstein, J D Whitet
Critical Reviews in Neurobiology|March 20, 2001
Impairment of GABAergic transmission in depression: new insights from neuroimaging studiesG Sanacora, G F Mason, J H Krystal
Endocrinology|August 1, 1990
Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivationG Sanacora, M Kershaw, J A Finkelstein, et al.
The Journal of ECT|April 3, 2001
ECS-Induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatmentA C Chen, K H Shin, R S Duman, et al.
General Hospital Psychiatry|August 14, 2018
Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editorR B Katz, M Toprak, S T Wilkinson, et al.
The Medical Clinics of North America|May 15, 2001
Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disordersJ H Krystal, D C D'Souza, G Sanacora, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 20, 2016
Balancing the Promise and Risks of Ketamine Treatment for Mood DisordersG Sanacora, H Heimer, D Hartman, et al.
Molecular Psychiatry|October 1, 2008
Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzoleM Banasr, G M I Chowdhury, R Terwilliger, et al.
Pageof 2